Tower Research Capital LLC (TRC) - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 73 filers reported holding IMMUNE DESIGN CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$2,000
-95.3%
1,204
-90.4%
0.00%
-100.0%
Q3 2018$43,000
+104.8%
12,548
+135.3%
0.00%0.0%
Q4 2017$21,000
-8.7%
5,333
+139.7%
0.00%
+50.0%
Q3 2017$23,0002,225
+10013.6%
0.00%
Q1 2017$0
-100.0%
22
-98.9%
0.00%
-100.0%
Q4 2016$11,000
-87.1%
2,019
-81.9%
0.00%
-87.5%
Q3 2016$85,000
+1600.0%
11,134
+1746.4%
0.01%
Q2 2016$5,000
-16.7%
603
+26.9%
0.00%
-100.0%
Q1 2016$6,000
-62.5%
475
-40.3%
0.00%
-66.7%
Q4 2015$16,000
-23.8%
795
-21.4%
0.00%
+50.0%
Q2 2015$21,000
+23.5%
1,012
+27.0%
0.00%0.0%
Q1 2015$17,0007970.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Svennilson Peter 6,642,942$8,636,0007.61%
Versant Venture Management, LLC 2,208,210$2,870,673,0001.42%
BVF INC/IL 5,185,383$6,741,0000.88%
EcoR1 Capital, LLC 5,603,191$7,284,0000.73%
Abingworth LLP 352,300$458,0000.42%
Bain Capital Public Equity Management, LLC 892,061$1,160,0000.11%
ALGERT GLOBAL LLC 92,591$120,0000.03%
GSA CAPITAL PARTNERS LLP 41,068$53,0000.01%
OXFORD ASSET MANAGEMENT LLP 136,468$177,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 27,122$35,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders